TRACE GENOMICS ABC – Trademark Portfolio
Entity Type: 16
TRACE GENOMICS ABC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include SSP, TESS, TRACE, TRACEN, and TRACEPHOS. The owner is based in LOS ANGELES, CA.
333 SOUTH GRAND AVENUE
SUITE 4100
LOS ANGELES, CA 90071
Showing of trademarks Trademarks
Trademark Classifications
TRACE GENOMICS ABC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does TRACE GENOMICS ABC have?
TRACE GENOMICS ABC has 11 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned.
What trademark classes does TRACE GENOMICS ABC file in?
TRACE GENOMICS ABC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TRACE GENOMICS ABC's most well-known trademarks?
TRACE GENOMICS ABC's registered trademark portfolio includes well-known marks such as SSP, TESS, TRACE, TRACEN, and TRACEPHOS. These are among 10 currently registered trademarks in the portfolio.
What is TRACE GENOMICS ABC's trademark registration success rate?
TRACE GENOMICS ABC has a 91% trademark registration rate, with 10 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.